Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the first patient has been dosed in a Phase III clinical ...
From cutting heart valves without open-heart surgery to confronting Israel’s growing medical brain drain, Sheba cardiologist ...
A webcast of the panel discussion will be available in the Investors section of Nuvectis’ website at www.nuvectis.com. About Nuvectis Pharma, Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results